Dr. Rosalyn Abbott is an associate professor at Carnegie Mellon University (CMU) in the Biomedical Engineering Department.

First-in-class drugs are often considered a signifier of innovation in drug discovery; however, they can also carry substantial uncertainty. A new comparison of approval data for first-in-class drugs ...

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million people in the world living with HIV. Although the government in Uganda provides ...

A UT Southwestern study finds that higher cardiorespiratory fitness may slow age-related brain atrophy, preserving cognitive ...

Trial of strength at the cellular level: cells are in constant competition with each other and so eliminate diseased or unwanted cells. Cell competition is therefore a central principle for ...

Some of the most popular potato cultivars were bred many decades ago. The reason for this limited success is the complex ...

A study reveals that populations with access to plant-based protein sources have longer life expectancies. The research shows ...

A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...

Researchers have found a rare form of one-dimensional quantum magnetism in a metallic compound for only the second time ever, ...

Researchers have identified a novel strategy for treating an aggressive form of leukemia – reprogramming the cancer cells to ...

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly ...

What if we could reprogram the immune system to tolerate respiratory allergens rather than react with inflammation?